The study was not powered to see how much better or worse it would be vs Eylea. (In reply to my last comment on this thread.)
- Forums
- ASX - By Stock
- Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
The study was not powered to see how much better or worse it...
-
- There are more pages in this discussion • 117 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
|
|||||
Last
44.0¢ |
Change
0.030(7.32%) |
Mkt cap ! $535.5M |
Open | High | Low | Value | Volume |
42.0¢ | 44.0¢ | 42.0¢ | $540.3K | 1.267M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 52220 | 43.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
44.0¢ | 76415 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 52207 | 0.435 |
10 | 101305 | 0.430 |
6 | 71397 | 0.425 |
10 | 129434 | 0.420 |
8 | 352889 | 0.415 |
Price($) | Vol. | No. |
---|---|---|
0.440 | 81829 | 8 |
0.445 | 78364 | 6 |
0.450 | 102482 | 6 |
0.455 | 293277 | 7 |
0.460 | 45150 | 2 |
Last trade - 15.13pm 29/07/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |